Study: Long COVID ‘brain fog' linked to inflammation, stress markers
A new study indicates the debilitating 'brain fog' suffered by millions of long COVID patients is linked to changes in the brain, including inflammation and an impaired ability to rewire itself following COVID-19 infection.
United Press International reported this week that the small-scale study, conducted by researchers at Corewell Health in Grand Rapids, Michigan, and Michigan State University, shows that altered levels of a pair of key brain chemicals could be the culprit.
The study marks the first time doctors have been able to provide scientific proof that validates the experiences of the approximately 12 million COVID 'long-haulers' in the U.S. who have reported neurological symptoms.
Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an anti-inflammatory protein that is crucial to regulating a person's immune system, UPI reported. They also showed lower serum levels of nerve growth factor, a protein vital to the brain's plasticity.
The study examined 17 COVID-19 patients, including 10 who still experienced symptoms six months after contracting the virus. The most debilitating symptom is brain fog, described by Yale Medicine as 'sluggish' thinking, forgetfulness, difficulty processing information and an inability to focus or concentrate on tasks they used to complete with ease.
The National Library of Medicine describes plasticity as the ability of the brain to change its activity in response to illness or injury. That healing process includes reorganizing the brain's structure, functions or connections.
One of the biggest issues involving long COVID has been doctors' inability to find physical proof of the symptoms described by patients. The study has changed that, according to co-author Dr. Bengt Arnetz.
'We found biological changes, which I think [is a] very big strength for this study,' Arnetz said, according to UPI. 'In parallel with the effects on executive function, we also saw that [NGF], which reflects the brain's ability to adapt to grow new neurons and connection, was suppressed in long COVID. This is aligned with the findings in the neuro-cognitive test.'
For the neuro-cognitive test, researchers put study participants through a battery of psychological exams. The results were unremarkable for all the exams except one — the 'letter fluency' test.
Arnetz's co-author, clinical neuropsychologist Michael Lawrence, explained that a fluency test measures a person's executive functioning under time constraints. It requires a patient to generate words beginning with a specified letter of the alphabet or to name items from a specific category, like animals or fruit.
Errors or difficulty performing the task are indicative of executive functioning impairments as well as impairments in memory and language. According to the Library of Medicine, similar impairments are found in conditions like Alzheimer's disease, vascular dementia and Lewy body dementia.
Lawrence said he believes the study is helpful because 'now we have some objective findings that really confirm what patients are describing and feeling.'
Identifying long COVID sufferers through the identified biomarkers could help the medical community develop multidisciplinary treatment for their symptoms, he said.
'I think patients and our medical community, at least years ago, tended to separate the mental health from the physical. But what we know is they're all very interconnected,' Lawrence said. 'The more we can improve mental health-related symptoms, what we see is decreased reports of pain and fatigue. We really need to treat the whole person, but we need to treat it early.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
an hour ago
- The Hill
Top CDC COVID vaccine advisor resigns following RFK Jr. recommendation change
A top coronavirus vaccine adviser to the Centers for Disease Control and Prevention (CDC) resigned from the agency, citing concerns that she would no longer be able to help the most vulnerable people following a change in the agency's recommendations for healthy children and pregnant women. In an email to colleagues, Lakshmi Panagiotakopoulos said the decision to leave was a 'personal' one. 'My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population, and that is not something I am able to continue doing in this role,' she wrote in an email viewed by The Hill. She said she made her decision Friday. Her resignation was first reported by Reuters. Panagiotakopoulos served as the co-leader of the coronavirus vaccine working group of agency staff and outside experts that aided the agency's Advisory Committee on Immunization Practices (ACIP), an outside expert panel that makes vaccine policy recommendations. The working group focuses exclusively on COVID-19 vaccines, reviewing the safety and efficacy data to inform the ACIP recommendations. The committee is scheduled to meet on June 25-27, and it is expected to deliberate and vote on recommendations for use of COVID-19 vaccines. The email from Panagiotakopoulos did not further detail her reasons for leaving. But it comes a week after Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced on social media that the CDC would no longer recommend that 'healthy' children and pregnant women get the COVID-19 vaccine. The CDC had previously recommended annual COVID-19 vaccines for everyone aged six months and older. Kennedy's announcement upended the traditional process for vaccine policy by bypassing ACIP entirely. During its previous meeting in April, committee members seemed inclined to switch to a risk-based vaccination strategy targeting only the most vulnerable, but they did not vote. Last week the CDC seemingly contradicted Kennedy by continuing to recommend children receive the shot after consulting with the doctor. But the agency no longer recommended pregnant women get the shot.
Yahoo
2 hours ago
- Yahoo
A new COVID-19 variant, vaccine changes: What to know in 2025
Like it or not, COVID-19 is still a public health issue five years after the start of the pandemic flipped the nation, and the world, on its head. Changing vaccination guidelines, ever-evolving variants and strains, threats to health insurance and more mean COVID is still very much a regular conversation on the lips of lawmakers, regulators and the general public. More than 40,000 positive tests were reported by the Centers for Disease Control and Prevention in May, and while hospitalizations and deaths are fortunately down significantly since the pandemic's peak, vulnerable people are still grappling with limiting their risk amid changing practices. Here is a brief recap of the status of COVID cases, variants and vaccines in the U.S. as of June 4, 2025. According to the most recent data on the CDC's COVID Data Tracker dashboard, there were 735 confirmed COVID-19 deaths in May 2025 as of May 24. In the four weeks leading up to May 24, 3% of 1,344,681 COVID tests administered nationwide were positive. In January, a new COVID-19 variant known as NB.1.8.1 was first detected in China. As of mid-May, the variant had reached 10.7% of global reported COVID-19 cases, according to the World Health Organization (WHO). As of May 27, less than 20 cases of NB.1.8.1 had been reported in the U.S., a CDC spokesperson told USA TODAY. This figure is too low to be added to the CDC's COVID Data Tracker dashboard, the spokesperson added, though they did not clarify the threshold for adding new variants to the dashboard. New COVID variant in China: Here's what to know about NB.1.8.1 NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, previously told USA TODAY. For comparison, LP.8.1 made up 70% of reported COVID-19 cases in the U.S. between April 26 and May 10, as reported by the CDC. Verma said NB.1.8.1 may be able to be transferred more easily than LP.8.1. Additionally, he said that NB.1.8.1 is able to evade antibodies created by vaccines or past infections more easily than LP.8.1. The variant has similar symptoms to other strains, including fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or a runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting. Health and Human Services Secretary Robert F. Kennedy Jr. said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process. Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection. RFK changes vaccine recommendations: Want a COVID vaccine? It could cost you $200. Insurance coverage typically follows federal recommendations, so anyone who is healthy and under 65 is likely to have to pay out of pocket to get the shot, which runs about $200, if they can get it. It's not clear what insurance companies will do about the new recommendations. RFK Jr. is a vaccine skeptic known for making false claims about vaccination and other medical practices. Under his leadership and the Trump administration, the FDA canceled the advisory meeting of independent experts who usually gather to formulate new flu shots annually and nixed a contract with Moderna to develop a bird flu vaccine amid the spread. He also pushed false claims about MMR vaccines as measles, previously eradicated in the U.S., began erupting in states across the country, causing the first death in a decade. It is not yet known how accessible the COVID-19 vaccine will be moving forward. Contributing: Karen Weintraub, Sudiksha Kochi, USA TODAY; Reuters This article originally appeared on USA TODAY: What to know about COVID-19 in 2025: Variants, vaccines, cases
Yahoo
2 hours ago
- Yahoo
Mosquito batch in McHenry County tests positive for West Nile Virus
MCHENRY COUNTY, Ill. — Health officials in McHenry County say they have identified a mosquito batch that tested positive for West Nile Virus (WNV) this week. According to officials from the McHenry County Department of Health (MCDH), a mosquito pool that was collected from Lake in the Hills, on Monday, June 2, tested positive for WNV. It is the first WNV-positive mosquito batch located in the county so far this year. Measles vaccination rates drop after COVID-19 pandemic in counties across the US Last week, mosquitoes from a batch found in Glenview tested positive for WNV. Following the discovery of WNV-positive mosquito batches in Dupage County last year, health officials warned the public to follow the '4 Ds of Defense' to avoid potential exposure: Drain: Drain items that collect standing water around homes, yards, or businesses and scrub and refill pet water dishes and birdbaths regularly. Defend: Use insect repellents that contain DEET when outdoors and reapply according to directions. Exercise may stop colon cancer from returning — and more Dress: Wear long pants, long sleeves, and closed-toe shoes to cover the skin when outside. Dusk to Dawn: Wear EPA-registered insect repellent outdoors during these prime times for mosquito activity. According to the West Nile Virus dashboard maintained by the Illinois Department of Public Health, there have been no human cases reported in the state so far this year. In 2024, the state saw 69 human cases, which resulted in 13 deaths. Sign up for our Medical Watch newsletter. This daily update includes important information from WGN's Dina Bair and the Med Watch team, including, the latest updates from health organizations, in-depth reporting on advancements in medical technology and treatments, as well as personal features related to people in the medical field. Sign up here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
